» Articles » PMID: 27383913

Macrophage Heterogeneity in the Context of Rheumatoid Arthritis

Overview
Specialty Rheumatology
Date 2016 Jul 8
PMID 27383913
Citations 270
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophages are very important in the pathogenesis of rheumatoid arthritis (RA). The increase in the number of sublining macrophages in the synovium is an early hallmark of active rheumatic disease, and high numbers of macrophages are a prominent feature of inflammatory lesions. The degree of synovial macrophage infiltration correlates with the degree of joint erosion, and depletion of these macrophages from inflamed tissue has a profound therapeutic benefit. Research has now uncovered an unexpectedly high level of heterogeneity in macrophage origin and function, and has emphasized the role of environmental factors in their functional specialization. Although the heterogeneous populations of macrophages in RA have not been fully characterized, preliminary results in mouse models of arthritis have contributed to our understanding of the phenotype and ontogeny of synovial macrophages, and to deciphering the properties of monocyte-derived infiltrating and tissue-resident macrophages. Elucidating the molecular mechanisms that drive polarization of macrophages towards proinflammatory or anti-inflammatory phenotypes could lead to identification of signalling pathways that inform future therapeutic strategies.

Citing Articles

Biomaterials for Modulating the Immune Microenvironment in Rheumatoid Arthritis.

Wang Q, Ji J, Huang D, Gao C BME Front. 2025; 6:0102.

PMID: 40065832 PMC: 11893043. DOI: 10.34133/bmef.0102.


Single cell immunoprofile of synovial fluid in rheumatoid arthritis with TNF/JAK inhibitor treatment.

Xia X, He C, Xue Z, Wang Y, Qin Y, Ren Z Nat Commun. 2025; 16(1):2152.

PMID: 40038288 PMC: 11880340. DOI: 10.1038/s41467-025-57361-0.


Targeting macrophage polarization by inhibiting Pim2 alleviates inflammatory arthritis via metabolic reprogramming.

Xu X, Xu P, Shen G, Peng X, Liu Z, Chen C Cell Mol Immunol. 2025; .

PMID: 40000906 DOI: 10.1038/s41423-025-01268-9.


Synovial macrophage diversity and activation of M-CSF signaling in post-traumatic osteoarthritis.

Knights A, Farrell E, Ellis O, Song M, Appleton C, Maerz T Elife. 2025; 12.

PMID: 39969512 PMC: 11839164. DOI: 10.7554/eLife.93283.


Constructing a 3D co-culture synovial tissue model for rheumatoid arthritis research.

Wang X, He J, Zhang Q, He J, Wang Q Mater Today Bio. 2025; 31:101492.

PMID: 39968522 PMC: 11834117. DOI: 10.1016/j.mtbio.2025.101492.


References
1.
Li J, Hsu H, Yang P, Wu Q, Li H, Edgington L . Treatment of arthritis by macrophage depletion and immunomodulation: testing an apoptosis-mediated therapy in a humanized death receptor mouse model. Arthritis Rheum. 2011; 64(4):1098-109. PMC: 3596268. DOI: 10.1002/art.33423. View

2.
Courties G, Heidt T, Sebas M, Iwamoto Y, Jeon D, Truelove J . In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. J Am Coll Cardiol. 2013; 63(15):1556-66. PMC: 3992176. DOI: 10.1016/j.jacc.2013.11.023. View

3.
Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S . Latent enhancers activated by stimulation in differentiated cells. Cell. 2013; 152(1-2):157-71. DOI: 10.1016/j.cell.2012.12.018. View

4.
Nerlov C, Graf T . PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 1998; 12(15):2403-12. PMC: 317050. DOI: 10.1101/gad.12.15.2403. View

5.
Hamilton J, Filonzi E, Ianches G . Regulation of macrophage colony-stimulating factor (M-CSF) production in cultured human synovial fibroblasts. Growth Factors. 1993; 9(2):157-65. DOI: 10.3109/08977199309010831. View